Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,897 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A higher CD34 + cell dose correlates with better event-free survival after KIR-ligand mismatched cord blood transplantation for childhood acute myeloid leukemia.
Ishida H, Kawahara Y, Tomizawa D, Okamoto Y, Hama A, Cho Y, Koh K, Koga Y, Yoshida N, Sato M, Terui K, Miyagawa N, Watanabe A, Takita J, Kobayashi R, Yamamoto M, Watanabe K, Okada K, Kato K, Matsumoto K, Hino M, Tabuchi K, Sakaguchi H. Ishida H, et al. Among authors: okada k. J Hematol Oncol. 2024 Apr 29;17(1):24. doi: 10.1186/s13045-024-01548-3. J Hematol Oncol. 2024. PMID: 38679709 Free PMC article.
Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia.
Kato M, Kurata M, Kanda J, Kato K, Tomizawa D, Kudo K, Yoshida N, Watanabe K, Shimada H, Inagaki J, Koh K, Goto H, Kato K, Cho Y, Yuza Y, Ogawa A, Okada K, Inoue M, Hashii Y, Teshima T, Murata M, Atsuta Y. Kato M, et al. Among authors: okada k. Bone Marrow Transplant. 2019 Jan;54(1):68-75. doi: 10.1038/s41409-018-0221-6. Epub 2018 May 24. Bone Marrow Transplant. 2019. PMID: 29795428 Clinical Trial.
Effect of extramedullary disease on allogeneic hematopoietic cell transplantation for pediatric acute myeloid leukemia: a nationwide retrospective study.
Sakaguchi H, Miyamura T, Tomizawa D, Taga T, Ishida H, Okamoto Y, Koh K, Yokosuka T, Yoshida N, Sato M, Noguchi M, Okada K, Hori T, Takeuchi M, Kosaka Y, Inoue M, Hashii Y, Atsuta Y. Sakaguchi H, et al. Among authors: okada k. Bone Marrow Transplant. 2021 Aug;56(8):1859-1865. doi: 10.1038/s41409-021-01250-9. Epub 2021 Mar 10. Bone Marrow Transplant. 2021. PMID: 33692532
Prognostic factors of children and adolescents with T-cell acute lymphoblastic leukemia after allogeneic transplantation.
Ishida H, Kato M, Kawahara Y, Ishimaru S, Najima Y, Kako S, Sato M, Hiwatari M, Noguchi M, Kato K, Koh K, Okada K, Iwasaki F, Kobayashi R, Igarashi S, Saito S, Takahashi Y, Sato A, Tanaka J, Hashii Y, Atsuta Y, Sakaguchi H, Imamura T. Ishida H, et al. Among authors: okada k. Hematol Oncol. 2022 Aug;40(3):457-468. doi: 10.1002/hon.2980. Epub 2022 Mar 3. Hematol Oncol. 2022. PMID: 35212019
Reduced-intensity allogenic transplantation for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Ishida H, Arakawa Y, Hasegawa D, Usami I, Hashii Y, Arai Y, Nishiwaki S, Keino D, Kato K, Sato M, Yoshida N, Ozawa Y, Okada K, Hidaka M, Yuza Y, Tanaka M, Watanabe K, Takita J, Kosaka Y, Fujita N, Tanaka J, Sato A, Atsuta Y, Imamura T. Ishida H, et al. Among authors: okada k. Ann Hematol. 2024 Mar;103(3):843-854. doi: 10.1007/s00277-023-05557-z. Epub 2023 Nov 25. Ann Hematol. 2024. PMID: 38006571
Comparison of intravenous with oral busulfan in allogeneic hematopoietic stem cell transplantation with myeloablative conditioning regimens for pediatric acute leukemia.
Kato M, Takahashi Y, Tomizawa D, Okamoto Y, Inagaki J, Koh K, Ogawa A, Okada K, Cho Y, Takita J, Goto H, Sakamaki H, Yabe H, Kawa K, Suzuki R, Kudo K, Kato K. Kato M, et al. Among authors: okada k. Biol Blood Marrow Transplant. 2013 Dec;19(12):1690-4. doi: 10.1016/j.bbmt.2013.09.012. Epub 2013 Sep 23. Biol Blood Marrow Transplant. 2013. PMID: 24071595 Free article.
Comparison of second transplantation and donor lymphocyte infusion for donor mixed chimerism after allogeneic stem cell transplantation for nonmalignant diseases.
Umeda K, Adachi S, Tanaka S, Miki M, Okada K, Hashii Y, Inoue M, Cho Y, Koh K, Goto H, Kajiwara R, Hyakuna N, Kato K, Morio T, Yabe H; Inherited Disease Working Group of the Japan Society for Hematopoietic Cell Transplantation. Umeda K, et al. Among authors: okada k. Pediatr Blood Cancer. 2016 Dec;63(12):2221-2229. doi: 10.1002/pbc.26141. Epub 2016 Aug 24. Pediatr Blood Cancer. 2016. PMID: 27554591
Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive cases.
Tomizawa D, Yoshida M, Kondo T, Miyamura T, Taga T, Adachi S, Koh K, Noguchi M, Kakuda H, Watanabe K, Cho Y, Fukuda T, Kato M, Shiba N, Goto H, Okada K, Inoue M, Hashii Y, Atsuta Y, Ishida H. Tomizawa D, et al. Among authors: okada k. Bone Marrow Transplant. 2019 Mar;54(3):393-401. doi: 10.1038/s41409-018-0273-7. Epub 2018 Jun 29. Bone Marrow Transplant. 2019. PMID: 29959436
Prophylaxis and treatment with mycophenolate mofetil in children with graft-versus-host disease undergoing allogeneic hematopoietic stem cell transplantation: a nationwide survey in Japan.
Kawashima N, Iida M, Suzuki R, Fukuda T, Atsuta Y, Hashii Y, Inoue M, Kobayashi M, Yabe H, Okada K, Adachi S, Yuza Y, Kawa K, Kato K. Kawashima N, et al. Among authors: okada k. Int J Hematol. 2019 Apr;109(4):491-498. doi: 10.1007/s12185-019-02601-5. Epub 2019 Jan 29. Int J Hematol. 2019. PMID: 30694451 Clinical Trial.
5,897 results